Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Williams Companies Inc (WMB) Price & Performance

Cassava Sciences IncTrade
Williams Companies IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Williams Companies Inc — how do they compare? Cassava Sciences Inc trades at $0.94 (market cap $47.75M), while Williams Companies Inc trades at $73.48 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 1852.4× Cassava Sciences Inc's market cap, and Williams Companies Inc pays a 2.9% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNAWMB
Market Cap
$47.75M$88.45B
Sector
HealthEnergy
52-Week High
$4.64$79.40
52-Week Low
$0.87$56.51
Enterprise Value
-$34.93M$119.07B
Dividend Yield
2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Williams Companies Inc

Williams Companies (WMB) trades at $71.85, up 2.06% today, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 EPS of $0.50, slightly missing estimates, but raised full-year EBITDA guidance. Recent news highlights the $5.5 billion acquisition of Momentum Midstream, enhancing its Gulf Coast presence and supporting long-term growth targets. Financials show strong profitability with a 25.18% net income margin and robust cash flow from operations of $5.90 billion in 2025.

Outlook remains positive with analyst consensus favoring Buy ratings (79.41%) and a $87.14 price target, though risks include execution of acquisitions and debt levels. The stock offers a dividend yield supported by stable cash flows, positioning it for growth in energy infrastructure demand.

Returns comparison

Trailing returns across standard periods

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Williams Companies Inc

Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.

Read more on WMB